Status:
COMPLETED
Bonefos and the Consumption of Analgesics
Lead Sponsor:
Bayer
Conditions:
Bone Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.
Eligibility Criteria
Inclusion
- Breast cancer or prostate cancer or multiple myeloma.
- Bone metastasis.
- Ability to use analgesics and clodronate 1600 mg/day.
Exclusion
- Hypersensitivity to bisphosphonates.
- Clodronate in previous therapy.
- Concomitant use of other bisphosphonates.
- Serious renal insufficiency.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT00909142
Start Date
April 1 2007
End Date
February 1 2009
Last Update
April 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Czechia